Delaware § 2525 Testing, screening, and treatment of health conditions [Effective June 30, 2026]

Delaware Statutes

§ 2525 — Testing, screening, and treatment of health conditions [Effective June 30, 2026]

Delaware·Title 24·Ch. 25 Pharmacy [Effective until June 30, 2026].·Subch. Prescription Labeling; Exemptions [Effective June 30, 2026].

(a)Pursuant to a statewide written protocol approved by the Division of Public Health, a pharmacist may order, test, screen, and treat health conditions that include all of the following:

(1)Influenza.

(2)Group A streptococcus pharyngitis.

(3)SARS-COV-2 or other respiratory illness, condition, or disease.

(4)Lice.

(5)Skin conditions, including ringworm and athlete’s foot.

(6)Other emerging and existing public health threats identified by the Division of Public Health if permitted by an order, rule, or regulation.

(b)A pharmacist who orders, tests, screens, or treats health conditions under this section may use any test that may guide clinical decision making that is waived under the federal Clinical Laboratory Improvement Amendments of 1988 [42 U.S.C. § 263a], or the federal

Free access — add to your briefcase to read the full text and ask questions with AI

(a) Pursuant to a statewide written protocol approved by the Division of Public Health, a pharmacist may order, test, screen, and treat health conditions that include all of the following:

(1) Influenza.

(2) Group A streptococcus pharyngitis.

(3) SARS-COV-2 or other respiratory illness, condition, or disease.

(4) Lice.

(5) Skin conditions, including ringworm and athlete’s foot.

(6) Other emerging and existing public health threats identified by the Division of Public Health if permitted by an order, rule, or regulation.

(b) A pharmacist who orders, tests, screens, or treats health conditions under this section may use any test that may guide clinical decision making that is waived under the federal Clinical Laboratory Improvement Amendments of 1988 [42 U.S.C. § 263a], or the federal rules adopted thereunder, or any established screening procedure that is established via a statewide protocol.

(c) A pharmacist may delegate the administrative and technical tasks of performing a test waived by the federal Clinical Laboratory Improvement Amendments of 1988 to an intern or pharmacy technician acting under the supervision of the pharmacist.

Delaware § 2525 (Testing, screening, and treatment of health conditions [Effective June 30, 2026]) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.